Toll-like receptor and hepatitis B virus clearance in chronic infected patients: A long-term prospective cohort study in Taiwan

Journal of Infectious Diseases

Volumn 206, Issue 5, 2012, Pages 662-668

  Wu, Jia Feng ^a   Chen, Chien Hung ^a   Ni, Yen Hsuan ^a   Lin, Ying Ting ^a   Chen, Huey Ling ^a   Hsu, Hong Yuan ^a   Chang, Mei Hwei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; FOLLOW UP; GENE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HETEROZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; SEROCONVERSION; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; TOLL LIKE RECEPTOR 2 GENE; TOLL LIKE RECEPTOR 4 GENE; TOLL LIKE RECEPTOR 5 GENE; TOLL LIKE RECEPTOR 9 GENE; VIRAL CLEARANCE; VIRUS LOAD;

CHILD; COHORT STUDIES; DNA; FEMALE; GENETIC VARIATION; GENOTYPE; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LOGISTIC MODELS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; TAIWAN; TOLL-LIKE RECEPTORS; VIRAL LOAD;

EID: 84864955687     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis420     Document Type: Article

References (33)

1. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet 1981; 2:1129-33.
2. Liu Z, Luo K, He H, Hou J. Hot-spot mutations in hepatitis B virus core gene: eliciting or evading immune clearance? J Viral Hepat 2005; 12:146-53. (Pubitemid 40342172)
3. Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977; 105:94-8. (Pubitemid 8042976)
4. Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 1986; 18:301-7.
5. Wu JF, Tsai WY, Hsu HY, et al. Effect of puberty onset on spontaneous hepatitis B virus e antigen seroconversion in men. Gastroenterology 2010; 138:942-8.
6. Ni YH, Chang MH, Chen PJ, et al. Viremia profile in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion. Gastroenterology 2007; 132:1287-93.
7. Chen YC, Chu CM, Liaw YF. Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B. Hepatology 2010; 51:435-44.
8. Fattovich G, Rugge M, Brollo L, et al. Clinical, virologic, and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986; 6:167-72. (Pubitemid 16144862)
9. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347:168-74.
10. Wu J, Lu M, Meng Z, et al. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 2007; 46:1769-78.
11. Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 2005; 79:7269-72. (Pubitemid 40677357)
12. Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in the liver. Gastroenterology 2006; 130:1886-900. (Pubitemid 43668871)
13. Dhiman N, Ovsyannikova IG, Vierkant RA, et al. Associations between SNPs in Toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine 2008; 26:1731-6.
14. Lian JQ, Wang XQ, Zhang Y, Huang CX, Bai XF. Correlation of circulating TLR2/4 expression with CD3 + /4 + /8 + T cells and Treg cells in HBV-related liver cirrhosis. Viral Immunol. 2009; 22:301-8.
15. Zhang Y, Lian JQ, Huang CX, et al. Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4( + )CD25( + ) regulatory T cells in chronic hepatitis B virus infection. Virology 2010; 397:34-42.
16. Xu Y, Hu Y, Shi B, et al. HbsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol. 2009; 46:2640-6.
17. Wu JF, Wu TC, Chen CH, et al. Serum levels of interleukin 10 and 12 predict early, spontaneous hepatitis B virus e antigen seroconversion. Gastroenterology 2010; 138:165-72.
18. Yeh SH, Tsai CY, Kao JH, et al. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 2004; 41:659-66.
19. Thursz M. Genetic susceptibility in chronic viral hepatitis. Antiviral Res 2001; 52:113-6. (Pubitemid 32973685)
20. Lin TM, Chen CJ, Wu MM, et al. Hepatitis B virus markers in Chinese twins. Anticancer Res 1989; 9:737-42.
21. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008; 48:335-52.
22. Hoebe K, Du X, Georgel P, et al. Identification of Lps2 as a key transducer of MyD88-indepandent TIR signaling. Nature 2003; 424:743-8. (Pubitemid 37021696)
23. Kurt-Jones EA, Popova L, Kwinn L, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2004; 101:5598-603.
24. Nan XP, Zhang Y, Yu HT, et al. Circulating CD4 + CD25high regulatory T cells and expression of PD-1 and BTLA on CD4 + sT cells in patients with chronic hepatitis B virus infection. Viral Immunol 2010; 23:63-70.
25. Visvanathan K, Skinner NA, Thompson AJ, et al. Regulation of Tolllike receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007; 45:102-10. (Pubitemid 46150869)
26. Wei C, Ni C, Song T, et al. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol. 2010; 185:1158-68.
27. Ferwerda B, McCall MB, Verheijen K, et al. Functional consequences of Toll-like receptor 4 polymorphisms. Mol Med 2008; 14:346-52. (Pubitemid 351785708)
28. Dhiman N, Ovsyannikova IG, Vierkant RA, et al. Associations between SNPs in Toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine 2008; 26:1731-6.
29. Lange NE, Zhou X, Lasky-Su J, et al. Comprehensive genetic assessment of a functional TLR9 promoter polymorphism: no replicable association with asthma or asthma-related phenotypes. BMC Med Genet. 2011; 12:26.
30. Romani L, Bistoni F, Perruccio K, et al. Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood 2006; 108:2265-74. (Pubitemid 44497509)
31. Song EY, Shin Y, Roh EY, et al. Serum HBsAg levels during peginterferon ?-2a treatment with or without thymosin ?-1 in HBeAg-positive chronic hepatitis B patients. J Med Virol 2011; 83: 88-94.
32. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR. Murine retrovirus activate B cells via interaction with Toll-like receptor 4. Proc Natl Acad Sci USA 2002; 99:2281-6. (Pubitemid 34169052)
33. Haynes LM, Moore DD, Kurr-Jones EA, Finberg RW, Anderson LJ, Tripp RA. Involvement of Toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 2001; 75:2281-6.